Mucocutaneous manifestations in newly diagnosed cases of HIV, correlation with CD4 counts and WHO staging at a tertiary care center
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20173928Keywords:
Mucocutaneous manifestations, Human Immunodeficiency Virus, CD4 counts, Candidiasis, Herpes zosterAbstract
Background:Mucocutaneous infections have played an important role in initial diagnosis of HIV infection and in clinical staging of the disease. Mucocutaneous manifestations in HIV infected individuals are myriad and can serve as a main indicator of other problems. Health care personnel involved in HIV health care must therefore have a clear idea of type, pattern, and prevalence of skin diseases in their locality. The objective of the study was to determine the various mucocutaneous manifestations in newly diagnosed cases of HIV and to correlate them with CD4 cell counts. The manifestations and CD4 cell counts are correlated with WHO staging of the disease.
Methods:Data was collected from all the newly diagnosed cases of HIV presenting to the Department of Dermatology. Thorough clinical examination was done and findings were noted. CD4 cell counts were performed by FACS counter and supportive laboratory tests were done for diagnosis of other skin manifestations.
Results:250 cases were enrolled with males 148 and 102 females. Most common age group was middle age group and hetero sexual route was the most common route of transmission. Bacterial skin infections were more common and candidiasis was most common among fungal infections. Herpes zoster was most common in viral infections. Significant correlation was observed between CD4 cell counts and WHO clinical staging of disease. Majority of infections were more common at advanced stage of HIV.
Conclusions:To conclude, HIV-related mucocutaneous manifestations are a good clinical clue in diagnosis of advanced stages of HIV. Most of these manifestations can serve as diagnostic and prognostic markers in HIV infection. Management of HIV related mucocutaneous manifestations should always be precluded with a screening of CD4 cell counts. A lowered CD4 cell counts will prolong the duration of treatment and may significantly alter the outcome of the disease.
References
UNAIDS. World AIDS Day 2014 Report – Fact sheet.Geneva,Switzerland,2014.http://www.unaids.org/en/resources/campaigns/World-AIDS Day-Report-2014/factsheet.
Foroughi M, Koochak HE, Roosta N, Paydary K, Khatami A, Shahriari S, et al. Prevalence of dermatologic manifestations among people living with HIV/AIDS in Imam Khomeini Hospital in Tehran, Iran J AIDS HIV Res. 2012;4:56–9.
Bunker CB, Gotch F. AIDS and the skin. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s Textbook of dermatology, 7th ed. Oxford; Blackwell science; 2005: 26-41.
World Health Organization, WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children, World Health Organization, Geneva, Switzerland, 2006.
WHO. Antiretroviral therapy in HIV infection in adults and adolescence in resource limited setting: towards universal access. 2006.
Operational Guidelines for Integrated Counselling and Testing Centres, NACO, 2007.
Uthayakumar S, Nandwani R, Drink Water T, Nayagam AT, Darley CR. The prevalence of skin disease in HIV infection and its relationship to degree of immunosuppression. Br J Dermatol. 1997;137:595-8.
Sharma S, Puri KJ, Gambhir ML. Male preponderance in HIV seropositive patients with mucocutaneous complaints in a tertiary care hospital in North India. Asian Pac J Trop Biomed. 2014;4186-8.
Srikanth KP, VS, Aparna. A hospital based cross sectional study of mucocutaneous manifestations in the HIV infected. Int J CRIMPH. 2010;2:50-78.
Singh H, Singh P, Tiwari P, Dey V, Dulhani N, Singh A. Dermatological manifestations in HIV-infected patients at a tertiary care hospital in a tribal (Bastar) region of Chhattisgarh, India. Indian J Dermatol. 2009;54(4):338–41.
Shobhana A, Guha SK, Neogi DK. Mucocutaneous manifestations in HIV infection. Indian J Dermatol Venereol Leprol. 2004;70:82–6.
Mawenzi RL, Oguttu OR, Williams HC, Joash A. Epidemiology and clinical spectrum of cutaneous diseases manifesting among newly diagnosed HIV seropositive adults in Nakuru county-Kenya. Continental J Med Res. 2013;7:1–9.
Salami TAT, Adewuyi GM, Echekwube P, Affusim C. Pattern of cutaneous pathology among a cohort of HIV/AIDS patients accessing care in a rural/suburban adult ART clinic in Nigeria. Br J Med Med Res. 2013;3:1199–207.
Spira R, Mingard M, Doutre MS, Molart P, Dabis F. Prevalence of cutaneous disorders in apopulation of HIV infected paients. Arch Dermatol. 1998;134:1208-12.
Garbe C, Husak R, Orfanos CE. HIV associated dermatoses and their prevalence in 456 HIV- infected patients. Relation to immune status and its importance as Diagnostic marker, Hautartz. 1994;45:623-9.
Chopra S, Arora U. Skin and Mucocutaneous Manifestations: Useful clinical predictors of HIV/AIDS. J Clin Diagn. 2012;6:1695-8.
Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol. 2011;21:149–53.
Huang XJ, Li HY, Chen DX, Wang XC, Li ZC, Wu YS, et al. Clinical analysis of skin lesions in 796 Chinese HIV-positive patients. Acta Derm Venerol. 2011;91:552–6.
Kim TJ, Lee KH, Oh SH. Skin disorders in Korean patients infected with HIV and their association with a CD4 lymphocyte count. a preliminary study. J Eur Acad venerol. 2010;24:1476-80.
Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Indian J Sex Transm Dis. 2013;34(1):19–24.
Raju PV, Rao GR, Ramini TV, Vandana S. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. 2005;44(8):646–9.
Kumarasamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP, Yesudian P. Dermatologic manifestations among HIV patients in south India. Int J Dermatol. 2000;39(3):192-5.
Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore. 1995;24:528– 33.
Han J, Lun WH, Meng ZH, Huang K, Mao Y, Zhu W, et al. Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China. J Euro Acad Dermatol Venereol. 2013;27(3):376.
Sharma YK, Sawhney MPS, Bhakuni DS, Gera V. Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting. Med J Armed Forces India. 2004;60(3):239–43.
